9Bio is a biotech company based in Quebec City, QC, focusing on the development of immuno-oncology therapeutics. Their AI-assisted structural biology platform considers both anatomical and biochemical contexts to help in the design of drugs aimed at selectively targeting tumours. This method is intended to create medicines that are more specific to tumours rather than healthy tissues, potentially enhancing safety and efficacy. The company's current pipeline comprises three therapies in the discovery stage.